Soluble, dimeric HLA DR4-peptide chimeras: An approach for detection and immunoregulation of human type-1 diabetes

European Journal of Immunology

Volumn 35, Issue 9, 2005, Pages 2762-2775

  Preda, Ioana ^a   McEvoy, Robert C ^b   Lin, Marvin ^a   Bona, Constantin A ^a   Rapaport, Robert ^a   Brumeanu, Teodor D ^c   Casares, Sofia ^a,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^d NONE   (United States)

Author keywords

Autoreactive CD4 T cells; Homeostasis; MHC II peptide complexes; Type 1 diabetes

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD4 ANTIGEN; GLUTAMATE DECARBOXYLASE 65; HLA DR4 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADOLESCENT; ADULT; ANTIGEN BINDING; ARTICLE; CELL MATURATION; CHILD; CHIMERA; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIMERIZATION; FEMALE; FLOW CYTOMETRY; GLUTAMATE DECARBOXYLASE; HLA-DR4 ANTIGEN; HUMANS; IMMUNOPHENOTYPING; ISOENZYMES; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS;

EID: 26044438468     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200526158     Document Type: Article

References (45)

1. Todd, J. A. and Wicker, L. S., Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 2001. 15: 387-395.
2. Schwartz, R. H., A cell culture model for T lymphocyte clonal anergy. Science 1990. 248: 1349-1356.
3. Casares, S., Bona, C. A. and Brumeanu, T. D., Engineering and characterization of a murine MHC class II-immunoglobulin chimera expressing an immunodominant CD4 T viral epitope. Protein Eng. 1997. 10: 1295-1301.
4. + T cells by a soluble, dimeric peptide-MHC class II chimera. Nat. Immunol 2002. 3: 383-391.
5. Masteller, E. L., Warner, M. R., Ferlin, W., Judkowski, V., Wilson, D., Glaichenhaus, N. and Bluestone, J. A., Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes. J. Immunol. 2003. 171: 5587-5595.
6. Zuo, L., Cullen, C. M., Delay, M. L., Thornton, S., Myers, L. K., Rosloniec, E. F., Boivin, G. P. and Hirsch, R., A single-chain class II MHC-IgG3 fusion protein inhibits autoimmune arthritis by induction of antigen-specific hyporesponsiveness. J. Immunol. 2002. 168: 2554-2559.
7. Trudeau, J. D., Kelly-Smith, C., Verchere, C. B., Elliott, J. F., Dutz, J. P., Finegood, D. T., Santamaria, P. and Tan, R., Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J. Clin. Invest. 2003. 111: 217-223.
8. George, S. K., Preda, I., Avagyan, S., McEvoy, R. C., Rapaport, R., Brumeanu, T. D., Casares S., Immunokinetics of autoreactive CD4 T cells in blood: a reporter for the "hit-and-run" autoimmune attack on pancreas and diabetes progression. J. Autoimmun. 2004. 23: 151-160.
9. + T cells directed to self-antigens. Eur. J. Immunol. 2003. 33: 1409-1417.
10. Casares, S., Zong, C. S., Radu, D. L., Miller, A., Bona, C. A. and Brumeanu, T.D., Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation. J. Exp. Med. 1999. 190: 543-553.
11. Thomas, S., Kumar, R., Preda-Pais, A., Casares, S. and Brumeanu, T. D., A model for antigen-specific T-cell anergy: displacement of CD4-p56(lck) signalosome from the lipid rafts by a soluble, dimeric peptide-MHC class II chimera. J. Immunol 2003. 170: 5981-5992.
12. Wicker, L. S., Chen, S. L., Nepom, G. T., Elliott, J. F., Freed, D. C., Bansal, A., Zheng, S. et al., Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele DRB1*0401. J. Clin. Invest. 1996. 98: 2597-2603.
13. Jefferis, R. and Lund, J., Interaction sites on human IgG-Fc for FcgammaR: current models. Immunol Lett. 2002. 82: 57-65.
14. Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S., Levings, M. K., Type 1 T regulatory cells. Immunol. Rev. 2001. 182: 68-79.
15. Fahmy, T. M., Bieler, J. G., Edidin, M. and Schneck, P., Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen. Immunity 2001. 14: 135-143.
16. Amrani, A., Verdaguer, J., Serra, P., Tafuro, S., Tan, R. and Santamaria, P., Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 2000. 406: 739-742.
17. Deenick, E. K., Gett, A. V. and Hodgkin, P. D., Stochastic model of T cell proliferation: a calculus revealing IL-2 regulation of precursor frequencies, cell cycle time, and survival. J. Immunol 2003. 170: 4963-4972.
18. Brumeanu, T. D., Bona, C. A. and Casares, S., T-cell tolerance and autoimmune diabetes. Int. Rev. Immunol. 2001. 20: 301-331.
19. + T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997. 389: 737-742.
20. Levings, M. K., Sangregorio, R., Galbiati, F., Squadrone, S., de Waal Malefyt, R. and Roncarolo, M. G., INF-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol 2001. 166: 5530-5539.
21. Groux, H., Bigler, M., de Vries, J. E. and Roncarolo, M. G., Interleukin-10 induces a long-term antigen-specific anergic stage in human CD4 T cells. J. Exp. Med. 1996. 184: 19-29.
22. + T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J. Invest. Dermatol. 2000. 114: 295-302.
23. Ozenci, V., Kouwenhoven, M., Huang, Y. M., Kivisak, P. and Link, H., Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment. Clin. Exp. Immunol. 2000. 20: 147-153.
24. Stratmann, T., Martin-Orozco, N., Mallet-Designe, V., Poirot, L., McGavern, D., Losyev, G., Dobbs, C. M. et al., Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. J. Clin. Invest. 2003. 112: 902-914.
25. Jang, M. H., Seth, N. P. and Wucherpfennig, K. W., Ex vivo analysis of thymic CD4 T cells in nonobese diabetic mice with tetramers generated from I-A(g7)/class II-associated invariant chain peptide precursors. J. Immunol. 2003. 171: 4175-4186.
26. Crawford, F., Kozono, H., White, J., Marrack, P. and Kappler, J., Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide chimeras. Immunity 1998. 8: 675-682.
27. Hackett, C. J., Sharma, O. K., Frontiers in peptide-MHC class II multimer technology. Nat. Immunol. 2002. 3: 887-889.
28. Reijonen, H., Novak, E. J., Kochik, S., Heninger, A., Liu, A. W., Kwok, W. W. and Nepom, G. T., Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 2002. 51: 1375-1382.
29. Danke, N. A., Koelle, D. M., Yee, C., Beheray, S. and Kwok, W. W., Autoreactive T cells in healthy, individuals. J. Immunol. 2004. 72: 5967-5972.
30. Schloot, N. C., Meierhoff, G., Karlsson Faresjo, M., Ott, P., Putnam, A., Lehmann, P., Gottlieb, P. et al., Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report for the third immunology of diabetes society T-cell workshop. J. Autoimmun. 2003. 21: 365-376.
31. Naik, R. G., Beckers, C., Wentwoord, R., Frenken, A., Duinkerken, G., Brooks-Worrell, B., Schloot, N. C., Palmer, J. P. and Roep, B. O., Precursor frequency of T-cells reactive to insulin in recent onset type 1 diabetes mellitus. J. Autoimmun. 2004. 23: 55-61.
32. Arif, S., Tree, T. I., Astill, T. P., Tremble, J. M., Bishop, A. J., Dayan, C. M., Roep, B. O. and Peakman, M., Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 2004. 113: 451-463.
33. Atkinson, M. A., Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 1992. 339: 458-459.
34. Alleva, D. G., Crowe, P. D., Jin, L., Kwok, W. W., Ling, N., Gottschalk, M., Coulon, P. J. et al., A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J. Clin. Invest. 2001. 107: 173-180.
35. Viglietta, V., Kent, S. C., Orban, T. and Hafler, D. A., GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J. Clin. Invest. 2002. 109: 895-903.
36. Harrison, L. C., Honeyman, M. C., DeAizpurua, H. J., Schmidli, R. S., Colman, P. G., Tait, B. D. and Cram, D. S., Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993. 329: 1365-1369.
37. Bendelac, A., Boitard, C., Bedossa, P., Bazin, H., Bach, J. F. and Carnaud, C., Adoptive transfer does not require recruitment of host B lymphocytes. J. Immunol. 1988. 8: 2625-2628.
38. Martin, S., Wolf-Eichbaum, D., Duinkerken, G., Scherbaum, W. A., Kolb, H., Noordzij, J. G. and Roep, B. O., Development of type 1 diabetes despite severe hereditary B-cell deficiency. N. Engl. J. Med. 2001. 345: 1036-1040.
39. Devendra, D., Yu, L. and Eisenbarth, G. S., Endocrine autoantibodies. Clin. Lab. Med. 2004. 24: 275-303.
40. Parolini, I., Sargiacomo, M., Lisanti, M. P. and Peschle, C., Signal transduction and glycophosphatidylinositol-linked proteins (lyn, lck, CD4, CD45, G proteins, and CD55) selectively localize in Triton-insoluble plasma membrane domains of human leukemic cell lines and normal granulocytes. Blood 1996. 87: 3783-3794.
41. Janes, P. W., Ley, S. C., Magee, A. I. and Kabouridis, P. S., The role of lipid rafts in T cell antigen receptor (TCR) signaling. Semin. Immunol. 2000. 12: 23-34.
42. Simons, K. and Ikonen, E., Functional rafts in cell membranes. Nature 1997. 387: 569-572.
43. Kassem, S. A., Ariel, I., Thornton, P. S., Scheimberg, I. and Glaser, B., β-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 2000. 49: 1325-1333.
44. Trudeau, J. D., Dutz, J. P., Arany, E., Hill, D. J., Fieldus, W. E. and Finegood, D. T., Neonatal β-cell apoptosis: a trigger for autoimmune diabetes? Diabetes 2000. 49: 1-7.
45. Bach, J. F., Regulatory T cells under scrutiny. Nat. Rev. Immunol. 2003. 3: 189-198.